Suppression of oral cancer by induction of cell cycle arrest and apoptosis using Juniperus communis extract

Ching-Chang Lee1,2, Chih-Yen Hsiao3,4, Shan-Chih Lee5,6

  • 1Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan, R.O.C.

Bioscience Reports
|August 29, 2020
PubMed

Insights

Juniperus communis extract (JCo) inhibits oral cancer growth by inducing cell cycle arrest and apoptosis. JCo also synergizes with 5-fluorouracil (5-FU), showing potential as an adjuvant cancer therapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • Oral cancer incidence is rising, posing a significant mortality risk.
  • Juniperus communis (J. communis) extract (JCo) shows prior anti-cancer activity.
  • Investigating JCo's anti-cancer mechanisms in oral cancer is warranted.

Purpose of the Study:

  • To elucidate the anti-cancer mechanisms of J. communis extract (JCo) on oral cancer cells.
  • To evaluate the synergistic effects of JCo combined with 5-fluorouracil (5-FU).

Main Methods:

  • Oral cancer cells were treated with J. communis extract (JCo).
  • Cell cycle progression, apoptosis, and signaling pathways (p53/p21, Rb) were analyzed.
  • Synergistic effects of JCo and 5-FU on cell viability were assessed.

Main Results:

  • JCo inhibited oral cancer cell proliferation and exhibited lower toxicity to normal cells.
  • JCo induced G0/G1 cell cycle arrest via p53/p21 and Rb signaling.
  • JCo promoted apoptosis through intrinsic and extrinsic pathways.
  • JCo demonstrated a synergistic effect with 5-FU in reducing cell viability.

Conclusions:

  • J. communis extract (JCo) inhibits oral cancer growth by inducing cell cycle arrest and apoptosis.
  • JCo exhibits significant synergy with 5-fluorouracil (5-FU).
  • JCo holds potential as an adjuvant and novel therapeutic agent for oral cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K